SC
TBIO

Steven Cohen’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Steven Cohen’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,778
Closed -$1.1M – 1277
2021
Q2 		$1.1M Buy
+2,778
New +$982K ﹤0.01% 793

Other funds holding TBIO

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

Steven Cohen's TBIO Position: Q3 2021 in Review

Steven Cohen sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 2,778 shares — an estimated $1.1M sold.

Steven Cohen first reported a position in TBIO in Q2 2021 and held it in 1 quarter. The position peaked at $1.1M in Q2 2021. 43 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Steven Cohen reported no remaining Telesis Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Steven Cohen sold 2,778 Telesis Bio, Inc. Common Stock shares in Q3 2021, an estimated $1.1M.
  • Steven Cohen first reported a position in Telesis Bio, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Steven Cohen's Telesis Bio, Inc. Common Stock position peaked at $1.1M in Q2 2021.
  • 43 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q3 2021.

Based on Point72 Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.